AstraZeneca Can't Dodge Nexium Antitrust Claims
A Massachusetts federal judge Wednesday largely kept intact multidistrict litigation brought by direct- and third-party purchasers that allege AstraZeneca PLC and several generic-drug makers violated antitrust laws by entering into agreements...To view the full article, register now.
Already a subscriber? Click here to view full article